2025 American Academy of Neurology Abstract Website

Disclosures for "SmartRehab: Enhancing Stroke Recovery through Automated Telerehabilitation"

Dr. Saleh Velez has nothing to disclose.
Mr. Yeung has stock in ReMobility Limited. The institution of Mr. Yeung has received research support from World Stroke Organization Future Leader Project. Mr. Yeung has received intellectual property interests from a discovery or technology relating to health care.
Camila Bonin Pinto has nothing to disclose.
Author has nothing to disclose
Matias Alet has nothing to disclose.
Leonardo Carbonera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allm. The institution of Leonardo Carbonera has received research support from World Stroke Organization . The institution of Leonardo Carbonera has received research support from Boehringer Ingelheim.
Dr. Ciopleias has nothing to disclose.
Prof. Yusof Khan has nothing to disclose.
Dr. Law has nothing to disclose.
Dr. Lotlikar has nothing to disclose.
Ms. Liu has nothing to disclose.
Mr. So has nothing to disclose.
Mr. Chan has nothing to disclose.
Ms. Poon has nothing to disclose.
Miss Boada Robayo has nothing to disclose.
Dr. Rudyk has nothing to disclose.
Dr. Kiper has nothing to disclose.
Andriy Yabluchanskiy has nothing to disclose.
Dr. Savitz has nothing to disclose.
Mr. LUO has nothing to disclose.
Dr. Fok has received personal compensation for serving as an employee of The University of Hong Kong. The institution of Dr. Fok has received research support from Innovation Technology Fund.
Miss Chen has nothing to disclose.
Mr. Lam has nothing to disclose.
Mr. Leung has nothing to disclose.
Dr. Caso has nothing to disclose.
Author has nothing to disclose
Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Daiichi Sankyo. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Amgen. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Daiichi Sankyo. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Pfizer. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai. Dr. Lau has stock in ReMobility. The institution of Dr. Lau has received research support from Croucher Foundation. The institution of Dr. Lau has received research support from Research Fund Secretariat of the Food and Health Bureau, Hong Kong. The institution of Dr. Lau has received research support from Innovation and Technology Bureau, Hong Kong. The institution of Dr. Lau has received research support from Research Grants Council, Hong Kong. Dr. Lau has received publishing royalties from a publication relating to health care.